SCHEMBL474976

SCHEMBL474976

CC(c1ccccc1-c1cccc(CC(=O)O)c1)C(O)(c1ccc2c(c1)n(C)c(=O)n2C)C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.39
PTGS2 P35354 1/20 0.36
PPARG P37231 1/20 0.36
FFAR1 O14842 3/20 0.36
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
CMA1 P23946 1/20 0.34
SELL P14151 2/20 0.34
SELP P16109 2/20 0.34
ALDH1A1 P00352 1/20 0.34
GLA P06280 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
PLA2G10 O15496 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12164010 0.86 PTGS2 (0.37) PTGDR2PTGS2PPARGFFAR1PPARD
SCHEMBL474492 0.86 PTGS2 (0.37) PTGDR2PTGS2PPARGFFAR1PPARD
SCHEMBL474975 0.82 ALDH1A1 (0.35) PTGDR2PTGS2CMA1ALDH1A1GLA
SCHEMBL474936 0.82 ADORA2A (0.42) PTGDR2PPARGPPARDPPARASMN1; SMN2
SCHEMBL474633 0.79 ALDH1A1 (0.41) CMA1ALDH1A1GLASMN1; SMN2MAPK14
SCHEMBL474933 0.78 PPARG (0.39) PTGDR2PPARGPPARDALDH1A1SMN1; SMN2
SCHEMBL474606 0.78 RXRA (0.40) PTGS2PPARGPPARDALDH1A1
SCHEMBL12164001 0.78 RXRA (0.40) PTGS2PPARGPPARDALDH1A1
SCHEMBL474521 0.77 TP53 (0.39) CMA1ALDH1A1GLASMN1; SMN2MAPK14
SCHEMBL474454 0.74 SMN1; SMN2 (0.39) PTGDR2PPARGFFAR1PPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411365-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2012-02-01 EP disclosed